Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Trypanosoma brucei (T. brucei) is the causative agent of the Human African Trypanosomiasis (HAT), which is a neglected disease with an endemic occurrence in 36 sub-Saharan African countries. The current standard of care suffers from low efficacy and severe side effects. Therefore, new drugs with bet...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Münzker Lena
Daljnji autori: Klebe, Gerhard (Prof. Dr.) (Savjetnik disertacije)
Format: Dissertation
Jezik:engleski
Izdano: Philipps-Universität Marburg 2019
Teme:
Pharmakologie, Therapeutik
Farnesylpyrophosphat-Synthase
Trypanosoma brucei
Fragment-basierte Wirkstoffentwicklung
farnesyl pyrophosphate synthase
Fragment-based drug discovery
Pharmacology & therapeutics, prescription drugs
Online pristup:PDF cijeli tekst
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti